drugset / Trial / NCT01466270
Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
Phase 2
Completed
62 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
RATIONALE: Donepezil hydrochloride may help lessen cognitive dysfunction caused by chemotherapy. PURPOSE: This phase II trial is studying donepezil hydrochloride in treating cognitive dysfunction after chemotherapy in female breast cancer survivors.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | — | Oral |